Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Daiichi Sankyo
H. Lee Moffitt Cancer Center and Research Institute
Daiichi Sankyo
sigma-tau i.f.r. S.p.A.